Anika Therapeutics

Anika Therapeutics is a global company dedicated to joint preservation and the advancement of orthopedic care. It focuses on developing clinically meaningful therapies aimed at improving the lives of patients suffering from degenerative orthopedic diseases and traumatic conditions. The company's primary areas of expertise include osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Anika actively collaborates with physicians to understand their needs and create minimally invasive products that enhance patient outcomes and promote active living. The majority of its revenue is generated from the United States, highlighting its significant presence in the orthopedic market.

Steve Griffin

CFO

3 past transactions

Parcus Medical

Acquisition in 2020
Parcus Medical, LLC is a manufacturer that specializes in designing, producing, and distributing surgical products for orthopedic surgeons. Founded in 2007, the company is based in Sturgeon Bay, Wisconsin, and operates as a subsidiary of Anika Therapeutics, Inc. Parcus Medical offers a wide range of products, including suture anchors, interference screws, tenodesis systems, graft fixation systems, and various surgical instrumentation. These products are specifically utilized in sports medicine procedures aimed at repairing injuries to the shoulder, knee, hip, and distal extremities. By providing innovative solutions, Parcus Medical supports orthopedic surgeons in restoring patient function and mobility.

Arthrosurface

Acquisition in 2020
Arthrosurface, Inc. is an orthopedic medical device company based in Franklin, Massachusetts, specializing in minimally invasive joint resurfacing systems. Founded in 2002, the company designs and manufactures implant systems for various joints, including the knee, shoulder, wrist, hip, foot and ankle, and toe, aimed at treating conditions related to trauma, injury, and arthritis. Its products are engineered to preserve native joint anatomy and biomechanics, allowing for improved range of motion and reduced pain. Arthrosurface's innovations, such as the HemiCAP system, enable patients to undergo procedures with shorter hospital stays and quicker recoveries, facilitating a return to active lifestyles. The company markets its devices through a network of sales representatives and distributors both in the United States and internationally. Since February 2020, Arthrosurface has operated as a subsidiary of Anika Therapeutics, Inc.

Fidia Farmaceutici

Acquisition in 2009
Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (HA) in joint care, wound healing, ophthalmology, aesthetic and autologous biological therapy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.